Skip to content

8-KAccepted Sep 16, 9:26 AM ET

Acumen Pharmaceuticals Announces Investor Day Webcast (Sept 16, 2026)

ABOSAcumen Pharmaceuticals, Inc.

Accepted (ET)

9:26 AM

Sep 16, 2026

Filed

Sep 16, 2026

Documents

71

Size

8.6 MB

Summary

Acumen Pharmaceuticals Announces Investor Day Webcast (Sept 16, 2026)

Updated

What Happened Acumen Pharmaceuticals, Inc. (ABOS) announced in a Form 8‑K (filed Sept. 16, 2026) that it will host an Investor Day on September 16, 2026, beginning at 10:00 a.m. Eastern Time. The event will be live‑webcast, and the webcast and the slide presentation used by the company’s executive team will be posted on Acumen’s investor relations website after the event. A copy of the presentation is attached to the filing as Exhibit 99.1. The report was signed by Matthew Zuga, Chief Financial Officer and Chief Business Officer.

Key Details

  • Event: Investor Day on September 16, 2026, start time 10:00 a.m. ET (live-webcast).
  • Materials: Slide presentation to be posted on the company’s investor relations website after the event and included as Exhibit 99.1 to the Form 8‑K.
  • Filing: Reported under Item 7.01 (Regulation FD Disclosure) of Form 8‑K; signed by CFO Matthew Zuga.

Why It Matters An Investor Day gives management a dedicated forum to present corporate strategy, program updates, and business outlook to shareholders and analysts. The live webcast and posted slide deck provide investors direct access to the presentation materials and any disclosures made during the event, improving transparency and allowing investors to review management’s public comments and supporting slides.

AI-written summary · check the filing